VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EMN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EMNEastman Chemical Company
$64.41$7.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. EMN
  4. Financial Ratios

Eastman Chemical Company (EMN) Financial Ratios

Latest Ratios: P/E Ratio 11.5x · EV/EBITDA 8.2x · ROE 8.0%. (1996–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

EMN Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$7.4B$7.4B$10.8B$10.7B$10.2B$16.6B$13.7B$11.0B$10.4B$13.5B$11.2B
Enterprise Value$11.9B$11.9B$15.2B$15.3B$14.8B$21.6B$18.7B$16.6B$16.4B$19.9B$17.6B
P/E Ratio →11.4815.5711.9111.9912.8319.3528.6514.469.679.1812.88
P/S Ratio0.810.841.151.170.971.581.621.191.031.421.25
P/B Ratio1.231.221.841.941.942.862.241.821.782.432.42
P/FCF15.7017.4015.6519.6427.9415.9212.9310.2310.2913.4314.71
P/OCF7.597.618.377.8110.4310.249.417.306.778.178.06

P/E links to full P/E history page with 30-year chart

EMN EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—1.361.621.661.412.062.211.791.622.091.96
EV / EBITDA8.258.238.069.619.5010.7811.038.567.899.418.28
EV / EBIT12.7615.3211.7411.7012.8016.9925.5014.8210.6213.0113.17
EV / FCF—28.0422.0828.0540.7420.7917.7015.4316.1519.7323.15

EMN Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin21.1%21.1%24.4%22.4%19.5%24.0%23.7%24.3%24.0%26.1%27.4%
Operating Margin10.6%10.6%14.7%11.9%10.3%14.0%13.3%14.3%14.6%16.1%17.2%
Net Profit Margin5.4%5.4%9.6%9.7%7.5%8.2%5.6%8.2%10.7%15.5%9.7%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE8.0%8.0%15.9%16.6%14.4%14.4%7.9%12.7%18.9%28.9%20.0%
ROA3.2%3.2%6.1%6.1%5.3%5.4%3.0%4.7%6.8%9.4%5.6%
ROIC6.7%6.7%10.1%8.2%7.8%10.0%7.4%8.5%9.3%10.0%10.6%
ROCE7.5%7.5%11.2%9.3%9.0%11.0%8.0%9.3%10.5%11.0%11.3%

EMN Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.840.840.900.930.980.950.920.961.051.171.43
Debt / EBITDA3.523.522.793.223.302.753.312.992.973.093.11
Net Debt / Equity—0.750.760.830.890.870.830.921.011.141.39
Net Debt / EBITDA3.123.122.352.882.982.522.972.882.863.003.02
Debt / FCF—10.646.438.4112.804.864.775.205.856.308.45
Interest Coverage3.733.735.995.826.166.643.595.056.486.265.17

EMN Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.371.371.511.351.161.561.741.861.821.591.60
Quick Ratio0.630.630.780.700.581.061.060.930.960.820.81
Cash Ratio0.210.210.310.210.150.150.280.110.120.100.10
Asset Turnover—0.590.620.630.720.680.530.580.630.590.58
Inventory Turnover3.493.493.574.244.485.304.684.214.864.664.62
Days Sales Outstanding—41.6645.6045.7944.2455.0165.3354.2753.4853.1749.41

EMN Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield5.1%5.2%3.5%3.5%3.7%2.3%2.6%3.1%3.0%2.2%2.4%
Payout Ratio80.4%80.4%41.9%42.1%48.0%43.8%74.9%45.2%29.4%20.1%31.4%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield8.7%6.4%8.4%8.3%7.8%5.2%3.5%6.9%10.3%10.9%7.8%
FCF Yield6.4%5.7%6.4%5.1%3.6%6.3%7.7%9.8%9.7%7.4%6.8%
Buyback Yield1.4%1.4%2.8%1.4%9.9%6.0%0.4%3.0%3.8%2.6%1.3%
Total Shareholder Yield6.5%6.5%6.3%4.9%13.6%8.3%3.1%6.1%6.9%4.8%3.7%
Shares Outstanding—$116M$118M$119M$125M$137M$137M$139M$143M$146M$148M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Persistent year-over-year revenue contraction

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Trailing Multiples Overstate Earnings Power

Based on EMN's reported figures, the trailing P/E of 16.03 compares with a forward P/E of 10.47, implying the market expects earnings to rise meaningfully from current trailing levels as the 2026 recovery takes hold.

The gap between trailing and forward earnings multiples suggests analysts view recent quarters as a cyclical trough rather than a new base, though the PEG of 4.98 indicates little growth-adjusted discount relative to expected expansion. Against an EV/EBITDA of 8.33 and a P/S of 0.86, the stock appears priced more like a commodity-linked intermediates producer than a specialty materials company, which may reflect skepticism about the durability of the circular-economy premium. Investors should monitor whether forward estimates hold, since the valuation case depends heavily on earnings normalization rather than current cash generation.

Margin Recovery Still Short of Prior Peak

As reported in financial statements, EMN's gross margin rebuilt from 17.1% in 2025Q4 to 22.3% in 2026Q2 and 2026Q3, yet remains below the 24.6% to 25.3% levels seen throughout 2024.

The operating margin path, falling from 16.8% in 2024Q4 to 6.1% in 2025Q4 before recovering to 12.1%, points to meaningful operating deleverage from a high fixed-cost base. The net margin of 10.6% in the latest quarter appears inflated relative to operating margin, suggesting below-the-line items or tax effects may be contributing, which warrants scrutiny before treating it as earning power. Sustained recovery toward 2024 margin levels would support a higher normalized earnings base, while failure to close the gap may indicate structural pressure from commodity intermediates.

Returns Rebuilding From a Compressed Base

According to recent SEC filings, EMN's ROIC has moved from 0.9% in 2025Q4 to 2.2% in 2026Q2 and 2.0% in 2026Q3, still well below the 2.6% to 2.8% range recorded through 2024.

The low absolute ROIC relative to a capital-intensive asset base of roughly $5.6B to $5.9B in net PP&E suggests the company has been earning returns below what its invested capital would ideally generate, particularly during the trough period. The ROE of 4.0% in 2026Q3 is modest and partly reflects a growing equity base, so improvement in returns depends on margin recovery rather than balance sheet changes alone. Investors may want to track whether ROIC can return to the mid-2% range on a sustained basis, as that would indicate the circular-economy investments are beginning to contribute.

Coverage Strong Despite Stable Debt Load

Based on EMN's reported figures, interest coverage improved from 1.23 in 2025Q4 to 5.45 in 2026Q3, while debt-to-equity held in a narrow 0.82 to 0.90 band across the ten-quarter window.

The sharp swing in interest coverage largely reflects the earnings trough rather than any change in debt service burden, since total debt has stayed between $5.0B and $5.3B throughout the period. Debt-to-EBITDA rising to 20.15 in 2025Q4 before falling to 12.36 illustrates how sensitive leverage optics are to quarterly earnings volatility, so trailing-period metrics may overstate risk at the trough. The more relevant question is whether EBITDA can sustain recent levels, because a return to trough-level earnings would likely push leverage metrics back into a range that could constrain financial flexibility.

Recovery Narrative Rests on Two Quarters

Based on EMN's reported quarterly figures, the bullish case depends on two consecutive quarters of improving margins and cash generation, a short window given trailing revenue still shows about -6.7% year-over-year contraction.

The most commonly misapplied ratio for a business like EMN is the forward P/E, because it assumes analyst earnings estimates will hold through a period of volume uncertainty and destocking; a forward multiple of 10.47 looks attractive only if estimates prove durable. A more appropriate lens would be normalized free cash flow yield across a full cycle, given that free cash flow margin swung from negative 11.0% in 2026Q1 to 8.2% in 2026Q3 due largely to working capital movements. The recovery thesis may be overstated if the restocking-driven volume gains fade, which would leave the stock trading on trailing earnings that have not yet demonstrated sustained normalization.

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus & Technical Research Suite
Open EMN Terminal

EMN Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

EMN — Frequently Asked Questions

Quick answers to the most common questions about buying EMN stock.

What is Eastman Chemical Company's P/E ratio?

Eastman Chemical Company's current P/E ratio is 11.5x. The historical average is 18.2x. This places it at the 21th percentile of its historical range.

What is Eastman Chemical Company's EV/EBITDA?

Eastman Chemical Company's current EV/EBITDA is 8.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.6x.

What is Eastman Chemical Company's ROE?

Eastman Chemical Company's return on equity (ROE) is 8.0%. The historical average is 16.1%.

Is EMN stock overvalued?

Based on historical data, Eastman Chemical Company is trading at a P/E of 11.5x. This is at the 21th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Eastman Chemical Company's dividend yield?

Eastman Chemical Company's current dividend yield is 5.12% with a payout ratio of 80.4%.

What are Eastman Chemical Company's profit margins?

Eastman Chemical Company has 21.1% gross margin and 10.6% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Eastman Chemical Company have?

Eastman Chemical Company's Debt/EBITDA ratio is 3.5x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.